A new scientific review released Monday found that COVID-19 infection at any time during pregnancy increases the risk of maternal mortality, severe maternal morbidity and adverse neonatal outcomes.
Led by Professor Emily Smith of George Washington University, the study integrated data from 12 different studies on the subject from 12 countries. Overall, this meta-study included 13,136 pregnant women of hers, including 1,942 of her pregnant women with confirmed or probable COVID-19 infection during pregnancy.
In over a dozen studies, 3% of pregnant women with COVID-19 required intensive care. In seven studies, 4% of pregnant women received critical care and were five times more likely to receive critical care than women in studies who were negative for COVID-19.
Compared with pregnant women without COVID-19, infected pregnant women were seven times more likely to die and 15 times more likely to be on a ventilator. They were also about five times more likely to develop thromboembolism, which refers to blood clots in veins.
Previous research on this topic suggested that COVID-19 infection leads to an increased risk of stillbirth, but this study did not find the same results. The study found that pregnant women with COVID-19 were more likely to be born prematurely, their babies had lower birth weights, and were more likely to be admitted to the neonatal intensive care unit after birth.
One of the limitations included in the meta-studies listed is that they do not consider the impact of different coronavirus subspecies. This is the result of seeds.
Overall, the study says that its findings “make global efforts to improve access to safe prevention and treatment an urgent priority” for pregnant women.
“These findings highlight the need for global efforts to prevent COVID-19 during pregnancy through targeted administration of vaccines and non-pharmaceutical interventions,” the study concluded. I’m here.
This study was published in the BMJ Global Health Journal.